ONESOURCE SPECIALTY PHARMA
Back to Balance Sheet
|
ONESOURCE SPECIALTY PHARMA Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|
| Total Liabilities | ₹7,550 Cr | ₹1,309 Cr | ₹2,009 Cr | ₹2,442 Cr |
What is the latest Total Liabilities ratio of ONESOURCE SPECIALTY PHARMA ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹7,550 Cr |
| Mar2024 | ₹1,309 Cr |
| Mar2023 | ₹2,009 Cr |
| Mar2022 | ₹2,442 Cr |
How is Total Liabilities of ONESOURCE SPECIALTY PHARMA Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹7,550 Cr | 476.97 | |
| Mar2024 | ₹1,309 Cr | -34.86 | |
| Mar2023 | ₹2,009 Cr | -17.75 | |
| Mar2022 | ₹2,442 Cr | - | |
Compare Total Liabilities of peers of ONESOURCE SPECIALTY PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ONESOURCE SPECIALTY PHARMA | ₹18,964.5 Cr | 0.2% | 5.5% | -15.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹465,711.0 Cr | 1.1% | 4.6% | 14.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹192,376.0 Cr | 0.6% | 8.3% | 8.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,655.0 Cr | 6.3% | 12.2% | 45.5% | Stock Analytics | |
| CIPLA | ₹113,979.0 Cr | -1.7% | -2.8% | -4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,204.7 Cr | -3.7% | -10.4% | -6% | Stock Analytics | |
ONESOURCE SPECIALTY PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ONESOURCE SPECIALTY PHARMA | 0.2% |
5.5% |
-15.2% |
| SENSEX | -2.7% |
-0.2% |
-8% |
You may also like the below Video Courses